Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
ACCESSWIRE•12/08/2026•09:33 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.